Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China

American Journal of Clinical Nutrition

Volumn 89, Issue 1, 2009, Pages 265-276

  Shannon, Jackilen ^a   King, Irena B ^b   Lampe, Johanna W ^b   Dao, Li Gao ^c   Ray, Roberta M ^b   Lin, Ming Gang ^b   Stalsberg, Helge ^d   Thomas, David B ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EPITHELIUM; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROCYTE; EVALUATION; FATTY ACID BLOOD LEVEL; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; DIET; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; YOUNG ADULT;

EID: 58149383650     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26077     Document Type: Article

References (33)

1. Newton P, Hannay DR, Laver R. The presentation and management of female breast symptoms in general practice in Sheffield. Fam Pract 1999;16:360-5.
2. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
3. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. Prognostic significance of benign proliferative breast disease. Cancer 1993;71:3896-907.
4. Baer HJ, Schnitt SJ, Connolly JL, et al. Adolescent diet and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev 2003;12:1159-67.
5. Baer HJ, Schnitt SJ, Connolly JL, et al. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev 2005;14:2889-97.
6. Rohan TE, Cook MG, Potter JD, McMichael AJ. A case-control study of diet and benign proliferative epithelial disorders of the breast. Cancer Res 1990;50:3176-81.
7. Rohan TE, Jain M, Miller AB. Alcohol consumption and risk of benign proliferative epithelial disorders of the breast: a case-cohort study. Public Health Nutr 1998;1:139-45.
8. Rohan TE, Jain M, Miller AB. A case-cohort study of diet and risk of benign proliferative epithelial disorders of the breast (Canada). Cancer Causes Control 1998;9:19-27.
9. Webb PM, Byrne C, Schnitt SJ, et al. A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev 2004;13:1106-13.
10. Maillard V, Bougnoux P, Ferrari P, et al. n-3 And n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int J Cancer 2002;98:78-83.
11. Zhu ZR, Agren J, Mannisto S, et al. Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease. Nutr Cancer 1995;24:151-60.
12. Bagga D, Anders KH, Wang HJ, Glaspy JA. Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr Cancer 2002;42:180-5.
13. London SJ, Sacks FM, Stampfer MJ, et al. Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 1993;85:785-93.
14. Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94:1445-57.
15. Shannon J, King IB, Moshofsky R, et al. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr 2007;85:1090-7.
16. Aaman TB, Stalsberg H, Thomas DB. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer 1997;71:333-9.
17. Rose HG, Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res 1965;6:428-31.
18. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-20.
19. Szklo MN, Nieto FJ. Epidemiology: beyond the basics. Gaithersburg, MD: Aspen Publishers Inc, 2000.
20. Breslow NE, Day NE. The analysis of case-control studies. In: Davis W, ed. Statistical methods in cancer research. Vol 1. IARC Scientific Publications, 1980.
21. Shannon J, Ray R, Wu C, et al. Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2005;14:81-90.
22. Li W, Ray RM, Lampe JW, et al. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer 2005;115:981-93.
23. Wu C, Ray RM, Lin MG, et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol 2004;160:945-60.
24. Lubin F, Wax Y, Ron E, et al. Nutritional factors associated with benign breast disease etiology: a case-control study. Am J Clin Nutr 1989;50:551-6.
25. Williams CM, Maunder K. Fatty acid compositions of inositol and choline phospholipids of breast tumours and normal breast tissue. Eur J Clin Nutr 1993;47:260-7.
26. Menendez JA, del Mar Barbacid M, Montero S, et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 2001;37:402-13.
27. Menendez JA, Ropero S, Lupu R, Colomer R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: relationship to lipid peroxidation and HER-2/neu expression. Oncol Rep 2004;11:1241-52.
28. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer 2007;109:180-7.
29. Russo C, Olivieri O, Girelli D, et al. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. Hypertension 1997;29:1058-63.
30. Nakamura MT, Cho HP, Clarke SD. Regulation of hepatic Δ-6 desaturase expression and its role in the polyunsaturated fatty acid inhibition of fatty acid synthase gene expression in mice. J Nutr 2000;130:1561-5.
31. Alò PL, Visca P, Trombetta G, et al. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 1999;85:35-40.
32. Menendez JA, Decker JP, Lupu R. In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells. J Cell Biochem 2005;94:1-4.
33. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83:S1467-76.